GlassScriptPhysician profile
David P Ellent
NPI 1427081710
$22,470.75
in general payments reported to CMS, 2019-2025
98 companies · $6,885 in 2025
The $6,885 reported for 2025 was more than what 85% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,863 · 2020: $1,313 · 2021: $1,834 · 2022: $4,369 · 2023: $2,622 · 2024: $3,583 · 2025: $6,885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $1,612 · Education: $376 · Gift: $19.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,083.27 |
| Travel and Lodging | $1,612.19 |
| Education | $375.88 |
| Gift | $19.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Onmark, INC. | $3,113.43 | 2024-2025 | |
| US Oncology Corporate, INC. | $2,289.31 | 2022-2025 | |
| Amgen INC. | $1,228.26 | 2019-2023 | Kyprolis, Blincyto, Lumakras |
| Astrazeneca Pharmaceuticals LP | $788.46 | 2019-2025 | Imfinzi, Tagrisso, Calquence |
| Glaxosmithkline, LLC. | $748.69 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Janssen Biotech, INC. | $725.28 | 2020-2025 | Rybrevant, Imbruvica, Erleada |
| Pfizer INC. | $666.01 | 2019-2025 | |
| Sobi, INC | $537.79 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $523.41 | 2019-2025 | Opdivo, Opdualag |
| Tempus Ai, INC | $436.48 | 2024-2025 | Xt Cdx |
| Merck Sharp & Dohme LLC | $416.52 | 2019-2025 | Keytruda, Welireg, Reblozyl |
| Daiichi Sankyo INC. | $409.97 | 2021-2025 | Enhertu |
| Rigel Pharmaceuticals, INC. | $389.26 | 2020-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Celgene Corporation | $384.36 | 2019-2025 | Pomalyst, Reblozyl, Opdualag |
| Seagen INC. | $371.71 | 2019-2023 | Padcev |
Show all 98 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $369.65 | 2019-2025 | Gilotrif |
| Astellas Pharma US INC | $367.44 | 2020-2025 | Xtandi, Padcev |
| Aveo Pharmaceuticals, INC. | $357.92 | 2021-2025 | Fotivda |
| Abbvie INC. | $331.96 | 2020-2025 | |
| Lilly USA, LLC | $330.20 | 2019-2025 | Jaypirca, Verzenio |
| Karyopharm Therapeutics INC. | $323.80 | 2020-2024 | Xpovio |
| Genentech USA, INC. | $317.90 | 2019-2025 | Venclexta, Tecentriq |
| Novartis Pharmaceuticals Corporation | $316.10 | 2021-2025 | Kisqali |
| Mckesson Specialty Care Distribution, LLC | $270.66 | 2019 | |
| Taiho Oncology, INC. | $265.56 | 2019-2025 | |
| Puma Biotechnology, INC. | $259.06 | 2021-2025 | |
| Genzyme Corporation | $252.06 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $243.75 | 2019-2025 | Soliris, Ultomiris |
| Adaptive Biotechnologies Corporation | $226.94 | 2021-2025 | Clonoseq |
| Regeneron Healthcare Solutions, INC. | $219.04 | 2019-2025 | Libtayo |
| Blueprint Medicines Corporation | $213.69 | 2023-2024 | Ayvakit |
| Bayer Healthcare Pharmaceuticals INC. | $212.92 | 2019-2025 | |
| Pharmacosmos Therapeutics INC. | $208.60 | 2021-2025 | Monoferric |
| Takeda Pharmaceuticals U.S.A., INC. | $197.10 | 2019-2025 | Ninlaro, Fruzaqla |
| Kite Pharma, INC. | $185.66 | 2020-2025 | Yescarta |
| Jazz Pharmaceuticals INC. | $177.62 | 2021-2025 | |
| Pharmaessentia USA Corporation | $167.35 | 2022-2025 | Besremi |
| Ipsen Biopharmaceuticals, INC | $161.09 | 2019-2024 | Onivyde, Tazverik |
| Eisai INC. | $156.52 | 2019-2025 | |
| Incyte Corporation | $151.81 | 2022-2025 | Jakafi, Monjuvi |
| Array Biopharma INC | $139.68 | 2023-2025 | Braftovi, Mektovi, Lorbrena |
| Cardinal Health 108 LLC | $137.51 | 2023 | |
| Boston Scientific Corporation | $129.98 | 2022-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Agios Pharmaceuticals, INC. | $125.46 | 2024-2025 | Pyrukynd |
| Deciphera Pharmaceuticals INC. | $116.27 | 2021-2025 | Romvimza, Qinlock |
| Sirtex Medical INC | $114.48 | 2023-2025 | Sir-Spheres Microspheres |
| Tersera Therapeutics LLC | $113.61 | 2024-2025 | Xermelo, Zoladex |
| Invivyd INC | $105.75 | 2025 | Pemgarda |
| Recordati_rare_diseases_inc. | $102.74 | 2024-2025 | Sylvant, Enjaymo |
| Dova Pharmaceuticals | $99.81 | 2019-2020 | |
| Fennec Pharmaceuticals, INC. | $96.90 | 2024-2025 | Pedmark, Fyarro |
| Abbott Laboratories | $89.37 | 2020-2021 | |
| Octapharma USA, INC. | $84.92 | 2023 | Octagam Immune Globulin (Human) |
| Mylan Institutional INC. | $84.20 | 2020 | |
| Organon LLC | $83.23 | 2022-2023 | Ontruzant |
| Beigene USA, INC. | $77.32 | 2020-2023 | Brukinsa |
| Dendreon Pharmaceuticals LLC | $77.22 | 2019-2025 | Provenge |
| Verastem, INC. | $72.16 | 2019 | |
| Caris Mpi, INC. | $67.05 | 2025 | Mi Cancer Seek |
| Novo Nordisk INC | $57.15 | 2024 | Rybelsus, Ozempic |
| Amneal Pharmaceuticals LLC | $54.94 | 2024-2025 | Alymsys, Avastin, Neupogen |
| Gilead Sciences, INC. | $53.99 | 2021-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $53.92 | 2022-2023 | Epkinly, Imbruvica |
| Immunocore Limited | $50.94 | 2025 | Kimmtrak |
| Servier Pharmaceuticals LLC | $50.48 | 2022 | |
| Myovant Sciences INC. | $46.56 | 2021 | |
| Foundation Medicine, INC. | $44.88 | 2019-2021 | |
| Morphosys, US INC. | $44.07 | 2021-2022 | |
| Cti Biopharma Corp. | $43.68 | 2022-2023 | Vonjo |
| Sun Pharmaceutical Industries INC. | $42.90 | 2022-2024 | |
| Sandoz INC. | $41.08 | 2021-2025 | |
| Genmab U.S., INC. | $39.81 | 2024 | Tivdak, Epkinly |
| Iovance Biotherapeutics, INC. | $36.95 | 2024 | Amtagvi |
| Janssen Pharmaceuticals, INC | $35.45 | 2020-2021 | |
| Blue Earth Diagnostics | $34.24 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $33.49 | 2023-2025 | Orgovyx |
| Adc Therapeutics America, INC. | $31.53 | 2024-2025 | |
| Secura Bio, INC. | $30.66 | 2022 | |
| Beone Medicines USA, INC. | $29.58 | 2025 | Tevimbra |
| Progenics Pharmaceuticals, INC. | $29.22 | 2022 | |
| Azurity Pharmaceuticals, INC. | $29.07 | 2024-2025 | Vivimusta, Danziten |
| Emd Serono, INC. | $27.62 | 2024 | |
| Fresenius Kabi USA, LLC | $26.60 | 2025 | |
| Springworks Therapeutics, INC. | $25.31 | 2025 | Gomekli |
| Mauna Kea Technologies, INC. | $25.30 | 2021 | |
| Tolmar, INC. | $24.95 | 2023 | |
| Stemline Therapeutics INC. | $24.56 | 2025 | Orserdu |
| Pharming Healthcare, INC. | $22.19 | 2025 | Ruconest |
| Teva Pharmaceuticals USA, INC. | $20.68 | 2020 | |
| Mirati Therapeutics, INC. | $17.04 | 2023 | Krazati |
| Ferring Pharmaceuticals INC. | $16.24 | 2025 | Adstiladrin |
| Inari Medical, INC. | $16.20 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tolmar Pharmaceuticals, INC. | $14.74 | 2022 | |
| Shorla Oncology INC. | $14.48 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.38 | 2019 | |
| Coherus Oncology, INC. | $13.97 | 2024 | |
| Acrotech Biopharma INC. | $11.97 | 2021 | |
| Pharmaand Gmbh | $8.93 | 2025 | Rubraca |
Drugs and devices associated with these payments
Rybrevant $423Xt Cdx $373Enhertu $350Vonjo $269Tavalisse $241Rezlidhia $241Keytruda $241Ayvakit $238Imbruvica $234Ojjaara $222Clonoseq $200Ibrance $184Fotivda $175Welireg $171Epkinly $171Monoferric $150Doptelet $148Opdivo $146Mektovi $140Braftovi $140Lenvima $139Libtayo $135Zepzelca $130Reblozyl $129Besremi $120Pluvicto $120Sir-Spheres Microspheres $114Therasphere Y90 Glass Microspheres 10 Gbq $113Nubeqa $110Pemgarda $106Xtandi $100Imfinzi $96.39Xpovio $96.39Pyrukynd $91.02Xermelo $89.50Soliris $85.00Octagam Immune Globulin (Human) $84.92Inqovi $84.75Lonsurf $84.75Synagis $82.70Akeega $82.22Erleada $82.22Gilotrif $80.53Jakafi $80.27Venclexta $77.83Ninlaro $76.57Sylvant $76.35Pomalyst $76.34Fruzaqla $76.27Pedmark $75.63Ultomiris $74.22Sarclisa $73.52Talzenna $73.27Lorbrena $71.65Stivarga $70.49Vitrakvi $70.49Tagrisso $68.96Mi Cancer Seek $67.05Inlyta $65.44Yescarta $64.68Rybelsus $57.15Orgovyx $55.79Enjaymo $55.63Opdualag $55.38Xofigo $53.69Darzalex $53.31Elahere $53.30Kimmtrak $50.94Onivyde $50.64Jaypirca $48.44Verzenio $48.44Kisqali $48.38Tukysa $47.90Elrexfio $47.17Adcetris $47.17Brukinsa $46.54Ontruzant $46.10Qinlock $45.78Romvimza $45.78Padcev $45.74Jemperli $44.88Zejula $44.88Gavreto $43.97Bosulif $39.06Amtagvi $36.95Kyprolis $36.80Blincyto $36.80Nerlynx $31.37Provenge $30.93Ozempic $30.56Alymsys $30.26Paxlovid $29.91Besponsa $29.91Tevimbra $29.58Wayrilz $28.46Scemblix $27.81Lupron Depot $27.47Lumakras $26.29Gomekli $25.31Eligard $24.95
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ellent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.